M
IMEPro
J44.9 Respiratory
Updated March 2026

Chronic obstructive pulmonary disease, unspecified

ICD-10 Code: J44.9 · Body Part: Head/Brain (TBI)

QME Evaluation Process

PFTs, imaging, occupational and smoking history. Chapter 5 respiratory impairment with apportionment analysis.

Typical Impairment Rating

10-65% WPI based on PFT severity

AMA Guides Edition

5th Edition

Common Treatments

+ Bronchodilators
+ Inhaled corticosteroids
+ Pulmonary rehabilitation

Related Conditions

Body Part Guide

Head/Brain (TBI) Evaluation Guide

Impairment rating methods, common conditions, and QME evaluation protocols

View Guide →

QME Specialties for Chronic obstructive pulmonary disease, unspecified

Find a QME Specialist

Browse QME-certified physicians who evaluate chronic obstructive pulmonary disease, unspecified and related head/brain (tbi) conditions in California.

Browse Neurology Physicians →

Frequently Asked Questions

What is Chronic obstructive pulmonary disease, unspecified (J44.9)?

Chronic obstructive pulmonary disease, unspecified is an ICD-10 diagnosis code (J44.9) classified under Respiratory conditions. It affects the Head/Brain (TBI) and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.

How is J44.9 rated for impairment?

The typical whole person impairment (WPI) range for Chronic obstructive pulmonary disease, unspecified is 10-65% WPI based on PFT severity. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.

What is the QME evaluation process for J44.9?

PFTs, imaging, occupational and smoking history. Chapter 5 respiratory impairment with apportionment analysis.

What treatments are common for Chronic obstructive pulmonary disease, unspecified?

Common treatments for Chronic obstructive pulmonary disease, unspecified include Bronchodilators, Inhaled corticosteroids, Pulmonary rehabilitation. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.